Anthem, Inc. (NYSE:ANTM) – SVB Leerink increased their FY2021 earnings estimates for Anthem in a report issued on Thursday, October 21st. SVB Leerink analyst W. Mayo now forecasts that the company will post earnings of $25.93 per share for the year, up from their previous estimate of $25.73. SVB Leerink currently has a “Market Perform” rating and a $430.00 target price on the stock. SVB Leerink also issued estimates for Anthem’s Q4 2021 earnings at $5.04 EPS, Q1 2022 earnings at $7.81 EPS, Q2 2022 earnings at $7.45 EPS, Q3 2022 earnings at $7.35 EPS, Q4 2022 earnings at $5.62 EPS, FY2022 earnings at $28.38 EPS, FY2023 earnings at $32.46 EPS, FY2024 earnings at $37.13 EPS and FY2025 earnings at $42.61 EPS.
Anthem (NYSE:ANTM) last released its quarterly earnings data on Tuesday, October 19th. The company reported $6.79 EPS for the quarter, topping analysts’ consensus estimates of $6.37 by $0.42. The company had revenue of $35.55 billion for the quarter, compared to the consensus estimate of $35.35 billion. Anthem had a return on equity of 15.24% and a net margin of 3.27%. The company’s quarterly revenue was up 16.0% compared to the same quarter last year. During the same period last year, the business posted $4.20 EPS.
Anthem stock opened at $433.34 on Friday. The stock’s 50-day moving average is $376.41 and its 200-day moving average is $381.38. The company has a market cap of $105.65 billion, a price-to-earnings ratio of 25.46, a price-to-earnings-growth ratio of 1.07 and a beta of 1.03. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.49 and a quick ratio of 1.49. Anthem has a 12 month low of $269.01 and a 12 month high of $435.96.
Several institutional investors and hedge funds have recently modified their holdings of the company. Vanguard Group Inc. grew its position in shares of Anthem by 0.4% in the 2nd quarter. Vanguard Group Inc. now owns 18,910,421 shares of the company’s stock worth $7,219,998,000 after acquiring an additional 65,981 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in Anthem by 6.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,686,564 shares of the company’s stock valued at $4,553,842,000 after purchasing an additional 715,968 shares during the period. State Street Corp boosted its position in Anthem by 1.5% during the 2nd quarter. State Street Corp now owns 10,545,874 shares of the company’s stock valued at $4,026,415,000 after purchasing an additional 150,930 shares during the period. FMR LLC boosted its position in Anthem by 1.1% during the 2nd quarter. FMR LLC now owns 6,951,390 shares of the company’s stock valued at $2,654,041,000 after purchasing an additional 74,543 shares during the period. Finally, Capital International Investors boosted its position in Anthem by 5.9% during the 2nd quarter. Capital International Investors now owns 4,623,202 shares of the company’s stock valued at $1,765,129,000 after purchasing an additional 258,720 shares during the period. Institutional investors own 86.69% of the company’s stock.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 21st. Stockholders of record on Friday, December 3rd will be given a $1.13 dividend. The ex-dividend date is Thursday, December 2nd. This represents a $4.52 annualized dividend and a dividend yield of 1.04%. Anthem’s payout ratio is 20.11%.
Anthem Company Profile
Anthem, Inc provides life, hospital and medical insurance plans. It offers a broad spectrum of network-based managed care health benefit plans to the large and small employer, individual, Medicaid, and Medicare markets. The company operates through the following segments: Commercial & Specialty Business, Government Business, IngenioRx and Other.
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.